The War on Ivermectin

Ivermectin protocols can be found here.

STORY AT-A-GLANCE

• In his book, “The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the COVID Pandemic,” Dr. Pierre Kory details the history of ivermectin and the how and why behind Big Pharma’s suppression of this drug when it was found to work against COVID-19
• After spending his career as an internist and critical care physician, Kory has now turned his attention to long-haul COVID and post-jab injury syndromes
• Daily ivermectin use is a mainstay of the treatment plans for long-haulers and those with COVID jab injuries, as the drug very effectively binds to the toxic spike protein that is causing most of the damage in both of these conditions
• Methylene blue can be helpful for those struggling with crippling fatigue, as it boosts mitochondrial respiration and improves energy metabolism. It’s actually the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs used to treat COVID-19 along with zinc
• “The War on Ivermectin” reveals the disinformation playbook used by Big Pharma and its many allies to suppress highly useful and inexpensive medicines in order to protect and increase corporate profits

In this interview, return guest Dr. Pierre Kory discusses his new book, “The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the COVID Pandemic.” In it, he details the history of ivermectin and the how and why behind Big Pharma’s suppression of this drug when it was found to work against COVID-19.

Like Dr. Paul Marik and Dr. Peter McCullough, Kory has been threatened by the American Board of Internal Medicine, which is seeking to yank his medical license. While a family doctor in private practice can operate without board certification, most medical centers will not hire a doctor who isn’t board certified in his specialty, and insurance companies won’t put you on their panel.

Kory’s Response to the American Board of Internal Medicine

Kory, however, is not overly concerned about this threat — which is really little more than an intimidation tactic to shut him up — as he has no intention of ever going back to a hospital setting.

“I’m done,” he says. “There’s no way I could walk into a hospital. I’ve just learned too much. I’ve learned too much about pharmaceutical control of almost all of the medical evidence. There’s no way I can fit. Now I’m a square peg in a round hole.

So, to be honest, I don’t think [losing my board certification] would have an impact. I am now in private practice. I have a bustling telehealth practice and I’m very happy. I’m outside the system, I can do and say and care for the patients in a manner that I best see fit.

Anyway, our reply [to the American Board of Internal Medicine] was different than Peter’s. He presented all the evidence to support all the statements they accused him of as being misinformation; very data driven, evidence-based.

What we did is, our lawyer looked at their policy on misinformation and the process of ‘convicting’ someone of misinformation, and it required that they provide us the evidence showing that we are wrong and misinformed.

But the letter to us was bizarre. It was this hodgepodge of statements that I’d made or written on my Substack, and it was just implied that that’s misinformation …

So, we wrote back very simply, ‘Excuse us, but your letter does not follow your own misinformation policy. We ask that you kindly reissue the letter with the evidence showing that we’re wrong.’ And we’ve gotten radio silence ever since.”

Kory’s New Specialty

After spending his career as an internist and critical care physician, Kory has now turned his attention to long-haul COVID and post-jab injury syndromes — complex chronic illnesses. To that end, he’s collaborating with doctors who’ve spent decades treating other tricky conditions, such as chronic Lyme disease, fibromyalgia and chronic fatigue syndrome.

“So, not only do I have a new career and practice, but also a new intellectual focus and it’s much more satisfying. I’m literally returning people to levels of function that they weren’t at before.

These were oftentimes healthy people with full careers, children, they exercised, ate right and now they’re fully disabled with numerous organ system complaints.

And I’ll tell you, getting them from 20% [function] to 40% [function] is a big deal, when they can actually do just a little bit more than they were doing before, and when you get them to 80%, it’s transformative.

But it’s way more challenging. And I tell my patients, ‘Listen, I have to be humble here. I’m trying to figure this out. I’m collaborating, I’m reading, I’m learning from you.’ I’m learning from each patient, because we’re doing a lot of empiric therapies.

We’re trying things, and so I learn. Each patient serves as their own control and I’m finding different things work on different patients. But the real challenge that I’m finding is that I don’t have any biomarkers or tests that I find helpful to direct therapies.

A lot of the tests are normal, even inflammatory markers. Clotting markers are normal, and yet I know that they have inflammatory processes and they’re thrombogenic. So, I wish there was more research and guidance.”

Treating Long-Haul COVID

One of the primary complaints of those struggling with what we’re now calling “long-haul COVID” is fatigue, a lack of energy to do even the most basic things. Since mitochondria are responsible for 90% of the energy production in your body, it stands to reason that impaired energy production in the mitochondria, or more simply, mitochondrial dysfunction, is at play.

The challenge is how to recover that function. One fascinating drug that can help in this regard is methylene blue, which helps mitochondrial respiration and improves brain energy metabolism. Methylene blue is actually the parent molecule for hydroxychloroquine and chloroquine, off-patent drugs commonly used to treat not only malaria but also COVID-19.

Best known as a fish tank antiseptic and textile dye for blue jeans, it was actually the first synthetic drug in modern history, developed in 1876. Since then, we’ve discovered it has many really important medicinal benefits. Importantly, it’s the only known antidote for metabolic poisons, i.e., any poison that interferes with oxygen transport or displaces oxygen, either from the blood or from the mitochondria.

Basically, as an electron cycler, methylene blue acts like a battery, but unlike other compounds that do the same thing, it doesn’t cause damaging oxidation in the process. You can review my interview with Dr. Francisco Gonzalez Lima here for more information.

If anything interferes with oxygenation or cellular respiration, such as cyanide, methylene blue is able to bypass that point of interference through electron cycling, thus allowing mitochondrial respiration, oxygen consumption and energy production to function as it normally would. And, the effect is typically felt within hours, as it increases, by about 30%, the ability of the mitochondria to produce ATP in the electron transport chain. Kory has also found it useful.

“My really sick patients use methylene blue,” he says. “Some of the really sick ones that aren’t responding to medicine, I send to a clinic where they do apheresis, ozone, methylene blue, infrared. One of them actually was discharged on oral methylene blue. And so, I want to figure out how to implement oral methylene blue.”

Trial and Error

Methylene blue is far from a cure-all, however. Any number of processes could be impacting your mitochondria, and they all need to be addressed. Adding to the complexity is that remedies that work really well in one long-hauler or COVID jab-injured patient often will not work for another, even though they present with very similar symptoms.

“We’ve [found] about six or seven different pathophysiologic mechanisms, and one of them is mitochondrial dysfunction, but I don’t know which is the predominant one in each patient,” Kory says. “I have no way of figuring that out. The only way I figure it out is by responses to therapy.

For instance, I had one young woman recently. I tried a number of therapies and what resurrected her, finally, was when I started to treat mast cell activation. I put her on antihistamine, famotidine [a heartburn medication], ketotifen [an asthma medication], and Boom.”

The Case for Sun Exposure

Daily sun exposure for about an hour around solar noon can also be important, as the near-infrared wavelengths will trigger melatonin production in your mitochondria, where you need it the most.

Melatonin is a potent antioxidant, so getting plenty of sunshine on bare skin is a simple way to reduce reactive oxygen species (ROS) that cause damage, and secondarily increase the efficiency of ATP production. Kory has been recommending this as well.

COVID Really Revealed the Level of Corruption in Science

During our conversation, the issue of medical journals came up, and their role in the corruption of science. Kory notes:

“That’s the other transformation that Paul [Marik] and I have undergone. We really looked to those journals thinking they were the most sophisticated and that was the top levels of science. But seeing what was published in those journals throughout COVID uncovered the absolute control by the pharmaceutical industry.

I mean, what appears in those journals is what they allow to appear in those journals. Period. I know of many positive studies of repurposed drugs rejected. We’ve seen them pull the following — JAMA and The New England Journal both — where instead of rejecting [the paper] they hold onto it as if they’re considering it, and then the rejection comes months later.

I’ve never heard of that in my career. Usually, when I’ve tried to submit manuscripts, they either say, ‘This is interesting. We’re sending it out for peer review,’ or they say, ‘This is not of sufficient interest to our readership at this time.’

They rejected positive trials of ivermectin. And then, probably the greatest and most saddening corruption that they pulled, is that they published the Together trial on ivermectin, which is so brazenly fraudulent and corrupt.

There are so many documented actions those investigators took in order to ensure they did not have a statistically significant benefit for ivermectin. Yet the New England Journal of Medicine published it. When you look at the design and the conduct of the trial, it should never be published. It was brazenly corrupt.

The investigators were all working for either their own companies or other companies whose sole job was to do research contracts for pharmaceutical companies. I mean, what would happen in their careers had they published a positive trial on ivermectin? That’s it. Bye. No more contracts.”

The War on Ivermectin

According to Kory, the idea for “The War on Ivermectin” was birthed after reading an article titled “The Disinformation Playbook,”1 published by the Union for Concerned Scientists. He explains:

“What happened is that after my ivermectin testimony2 [December 8, 2020, before Sen. Ron Johnson], which went viral and brought a lot of attention to the FLCCC … our protocols were looked in to. Doctors started prescribing ivermectin.

And I thought — this is how naive I was — I literally thought that we were providing a major intervention that would alter the trajectory of the pandemic, without question. It would reduce cases, hospitalizations and deaths, and now you have an effective early outpatient treatment. And I thought that news would be welcomed.

I thought the FLCCC would come out as heroes. It was really Paul who identified the data signal first. He said, ‘Wow. You got to see what these studies are starting to show.’ I jumped in right behind him. I was the first author of that comprehensive review paper.

I worked a lot and I got deeply expert on ivermectin. But what happened in the next few months is that everything started going sideways, and I could not figure it out. I saw hit pieces. To you, this is not news. You’re probably like, ‘Yep. I’ve seen that before.’

The thing is, I didn’t know. I didn’t know that what I was really doing — bringing forth data supporting the efficacy of a generic drug — that is poking the bear. And when I say poking the bear, what is anathema to the pharmaceutical industry and their whole business model is they cannot have generic off-patent drugs become standard of care. It obliterates the market for their pricing new pills.

I didn’t know I was stepping into a war. In the history of pharma, I don’t think any single medicine threatened as many [drug] markets and campaigns. The only other medicine that did that was hydroxychloroquine, but they already killed hydroxychloroquine in 2020.

I was coming out now with ivermectin, and it threatened hundreds of billions of dollars in perpetuity for these insanely lethal vaccines, monoclonal antibodies, remdesivir, paxlovid, molnupiravir — all of the markets for their novel new pills to enter. I mean, I don’t think any medicine has ever threatened that much of a market.

So, we were getting attacked. I did an interview with the Associated Press and the article that came out, I mean, I almost had a heart attack [reading it]. I saw unending attacks on ivermectin and it was coming in different directions. I saw academia getting all hot and bothered.

‘It’s a fringe medicine. It’s unproven. The trials are small.’ I saw all these narratives and I didn’t know they were narratives at the time. I thought people were being stupid … Now, I see everything. I see everything they do now, even before they do it, because they’re really predictable.”

READ MORE HERE